Prostate cancer heterogeneity: Discovering novel molecular targets for therapy-Reference-Cited by-同舟云学术

Prostate cancer heterogeneity: Discovering novel molecular targets for therapy

Published:2017-03 Issue: Volume:54 Page:68-73
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Ciccarese Chiara,Massari Francesco,Iacovelli Roberto,Fiorentino Michelangelo,Montironi Rodolfo,Di Nunno Vincenzo,Giunchi Francesca,Brunelli Matteo,Tortora Giampaolo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference36 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Tumor heterogeneity confounds and illuminates: assessing the implications;Kleppe;Nat Med,2014

3. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

4. Mutational heterogeneity in cancer and the search for new cancer-associated genes;Lawrence;Nature,2013

5. The molecular taxonomy of primary prostate cancer;Cancer Genome Atlas Research Network;Cell,2015

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative bioinformatics approach yields a novel gene expression risk model for prognosis and progression prediction in prostate cancer;Journal of Cellular and Molecular Medicine;2024-06

2. COL10A1 as a Prognostic Biomarker in Association with Immune Infiltration in Prostate Cancer;Current Cancer Drug Targets;2024-03

3. Epigenetic regulation of androgen dependent and independent prostate cancer;Advances in Cancer Research;2024

4. WITHDRAWN: JUN and ATF3 are deficient in prostate cancer patients and their delivery in vivo via lipid nanoparticles has therapeutic efficacy by enhancing immune surveillance;Pharmacological Research;2023-08

5. PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer;Journal of Translational Medicine;2023-07-06